Tirzepatide NZ cost: what UK residents searching from New Zealand need to know

Why NZ pricing comparisons don't translate to a UK decision

The search for tirzepatide NZ cost typically comes from one of two places: someone who has lived in New Zealand and is now in the UK, or someone who spotted a lower overseas figure and is wondering whether to source treatment from abroad. Both are understandable, but both run into the same wall.

New Zealand's Pharmac does not currently fund tirzepatide for weight management, and Mounjaro has not been approved by Medsafe for that indication. Any price you find attached to NZ tirzepatide is almost certainly a compounded version, a parallel import, or simply inaccurate copy. Compounded or unverified medicine sourced outside the licensed UK supply chain carries real risk, the MHRA has warned repeatedly about fake and substandard weight-loss pens, and in 2025 alone enforcement agencies seized roughly 20 million doses of illegally traded GLP-1 medicines worth around £45 million. Overseas comparisons are not the comparison to make.

The relevant question for anyone in the UK is what private, legitimate, clinically supervised tirzepatide costs here. That's a more useful starting point, and it's what the rest of this page covers. For a full breakdown of how UK private pricing works by dose, the tirzepatide cost guide on this site goes deeper.

What UK private tirzepatide actually costs, and what headlines often leave out

Since Eli Lilly's September 2025 UK list-price increase, private providers have repriced across the board. Reported figures for the highest doses now sit towards the upper end of the £149–£375 range mentioned above. Lower doses, including the 2.5mg starter and the 5mg step, typically sit at the lower end. You can explore what the 2.5mg starting dose costs in the UK, the 5mg cost page, the 10mg cost breakdown, or the 15mg cost breakdown if you want the specifics at a given strength.

What those headline numbers often omit: consultation fees (charged separately by some providers), prescription charges, delivery costs, and any fee for clinical reviews when you move up a dose. Some providers charge for aftercare support; others don't offer it at all. By the time those are added, a lower headline figure can arrive at a very similar real-world number, or higher.

At nume, one price covers everything listed in the bullets above. We are not trying to win on price. What that buys you is a service built around clinical rigour rather than volume: a prescriber reviews your case, not a checklist, and that review happens again before every repeat. If the lowest monthly figure is the deciding factor, there are providers who will compete on that. We don't.

The decision that actually matters: not cheapest, but clinically appropriate

Tirzepatide is a Prescription-Only Medicine in the UK. For a POM, price is a proxy for the wrong thing. The relevant questions are: is the pharmacy GPhC-registered and verifiable, is a qualified prescriber personally assessing your suitability, and is the medicine arriving through the licensed UK supply chain?

The GPhC register is publicly searchable, you can verify any online pharmacy before you hand over payment details. The MHRA has flagged sellers operating without proper licensing, particularly those offering these medicines without a prior clinical assessment. A conspicuously low price, or a discount code for a prescription medicine, is a reason to check more carefully, not a reason to proceed quickly.

Tirzepatide is licensed for adults with a BMI of 30 or above, or 27 and above where a weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea is present. A lower threshold applies for some ethnic backgrounds under NICE guidance. BMI alone does not determine suitability, the prescriber looks at the full clinical picture, including any conditions or medicines that might interact. NICE's appraisal of tirzepatide, TA1026, sets out how the medicine fits into weight management care.

How the nume consultation works, and what arrives when you're approved

The process is straightforward. You fill in the free consultation on the treatment page; a GPhC-registered Independent Prescriber reads it the same day. Identity is verified with a photo ID check, and weight is confirmed on a short video call. If treatment is clinically appropriate, the order is dispatched the same day for orders placed before 12pm on a working day.

What arrives is a DPD tracked delivery in plain, unbranded packaging the next working day, no indication of what's inside from the outside. The pen itself is a Mounjaro KwikPen: a pre-filled, once-weekly subcutaneous injection. Storage guidance and full instructions are in the Patient Information Leaflet inside the box, and the NHS tirzepatide medicines page covers common questions about the medicine in accessible detail. Clinical aftercare runs seven days a week, and every repeat is re-reviewed before dispatch. No subscription locks you in; you order when it suits you.

If you want to understand the treatment in more depth before starting, the weight loss treatments overview sets out what to expect from tirzepatide alongside a reduced-calorie diet and increased activity. Questions the page doesn't answer can go to our clinical team via the contact page.